Psoriasis is a chronic, lifelong skin condition, and scalp psoriasis is a common manifestation of this condition. Scalp psoriasis often requires separate treatment to psoriasis on other areas of the body because of the presence of hair, thinness of the skin and the visibility of this area, which may affect the person's quality of life and wellbeing. An increased understanding of the treatment options available for scalp psoriasis, management protocols and effective application techniques may result in improved outcomes for patients.
Psoriasis affects around 2% (approximately 1.8 million people) of the UK population. Although psoriasis is often thought of as a condition affecting older adults, it can occur at any point in the lifespan, and around one third of those with the condition experience their first incidence of psoriasis before the age of 16 years. While psoriasis can be managed with effective treatment, it cannot be cured and is often lifelong. This article offers a clinical overview of the different types of psoriasis, and the various treatment options that are available.
Psoriasis affects around 2% (approximately 1.8 million people) of the UK population. Although psoriasis is often thought of as a condition affecting older adults, it can occur at any point in the lifespan, and around one third of those with the condition experience their first incidence of psoriasis before the age of 16 years. While psoriasis can be managed with effective treatment, it cannot be cured and is often lifelong. This article looks at the effect psoriasis can have on the quality of life and wellbeing of children and young people with the condition, as well as the role school nurses can play in supporting them.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.